Junlong Wu, M.D.
@DragonMed_WU
Followers
36
Following
94
Statuses
30
Associate Professor & Attending Urologist in Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
Shanghai, China
Joined December 2016
RT @yao_zhu_sh: Thank you @MedCellPress for featuring our study on the cover. Prostate Ca is a highly heterogenous disease, with drug respo…
0
1
0
Great success of 14th Shanghai GU Oncology Academic Conference! Glad to meet and learn from @amerseburger @declangmurphy @AndreaNecchi @SFreedlandMD and Dr. Karim Fizazi. Looking forward further connections.
1
3
16
RT @cdrjournal: 🆕Newly Published Review! Focuses on #exosomes in #chemotherapy & #Immunotherapy resistance, revealing how they regulate an…
0
2
0
RT @urotoday: Heterogeneity of radiological progression patterns and association with outcomes in patients with metastatic #ProstateCancer.…
0
3
0
@Marnizasaad THANKS for your participation and sharing. Hope to get further cooperation in near future!
0
0
1
RT @DragonMed_WU: Great to publish our recent study on Molecular Cancer😀😀😀: Clinical effectiveness of a multitarget urine DNA test for urot…
0
1
0
Great to publish our recent study on Molecular Cancer😀😀😀: Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma detection: a double-blinded, multicenter, prospective trial See details at
0
1
3
RT @APCCC_Lugano: 🌟 Be part of a pivotal moment in advanced #prostatecancer managment at #APCCC24! Join global experts in consensus discu…
0
13
0
RT @Cancer_Cell: Online Now: Interferon-stimulated neutrophils as a predictor of immunotherapy response https://t.c…
0
74
0
RT @DrShariat: FINALLY - what I have been looking forward to prove for 20 years: the detection performance of DRE for PCa is so weak that…
0
268
0
RT @APCCC_Lugano: ✨ The Advanced Prostate Cancer Consensus Conference (APCCC) 2024 is fast approaching, and we're thrilled to unveil our pa…
0
24
0
RT @Cancer_Cell: Online Now: Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic cas…
0
55
0
RT @jteoh_hk: What an honour to join the Pujiang Prostate Cancer Summit! Very impressed by the quality of scientific content and the resear…
0
2
0
Honored to organize APPC NGI Preceptorship 2023 and present preliminary results of our IIT (ANGELA) by @yao_zhu_sh. Meet friends and learn a lot! Thank you so much for supporting @DrMLChua @RenuEapen @jteoh_hk @peterchiu_uro .
1
2
9
RT @drenriquegrande: ⚡️Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer #bladdercancer @TheLancetOncol h…
0
8
0
RT @urotoday: Inherited mutations in Chinese patients with upper tract #UrothelialCarcinoma #UTUC. #BeyondTheAbstract with @DragonMed_WU >…
0
1
0